{"id":"W3132433975","doi":"10.1016/j.cgh.2021.02.026","title":"Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related Enteropathy","year":2021,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Microscopic Colitis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"","keywords":"Vedolizumab; Medicine; Addressin; Enteropathy; Ulcerative colitis; Inflammatory bowel disease; Gastroenterology; Crohn's disease; Internal medicine; Immunology; Disease; Integrin; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003088989,0.0003955803,0.003396872,0.00009149246,0.00007973829,0.000005674375,0.0001628025,0.0006056219,0.0001502398],"category_scores_gemma":[0.0002675417,0.0002528805,0.001364183,0.00004636875,0.001003715,0.00001205796,0.0001010232,0.0004073692,0.00001122492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007820815,"about_ca_system_score_gemma":0.0004999723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008060733,"about_ca_topic_score_gemma":0.00004793225,"domain_scores_codex":[0.9964838,0.0006303059,0.001689549,0.0006786261,0.00006795785,0.0004497299],"domain_scores_gemma":[0.9966267,0.001653802,0.0005883498,0.000750111,0.00009581826,0.000285228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003018443,0.002187491,0.2834366,0.01215238,0.004233642,0.001206728,0.0001155189,5.714579e-8,2.569567e-7,0.0007106243,0.002076127,0.6908621],"study_design_scores_gemma":[0.004152527,0.005068507,0.009488643,0.002140825,0.007007524,0.001002883,0.00001155109,0.0000326575,1.211887e-7,0.0000383667,0.9709506,0.0001057733],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02001854,0.9761465,0.0000923103,0.0007373152,0.001188952,0.001631368,0.0001466663,0.00002355686,0.00001477181],"genre_scores_gemma":[0.001090469,0.997009,0.0001321057,0.000433091,0.0002483494,0.0004152315,0.0002439786,0.00004258119,0.0003852184],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9688745,"threshold_uncertainty_score":0.9999924,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07865903264127785,"score_gpt":0.4190182107537824,"score_spread":0.3403591781125046,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}